Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
Holders of 5% or more of MDGL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Madrigal Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Taub Rebecca | 13D/A | 7.80%1.81M shares | – | Dec 12, 20251 filing | Dec 12, 2025 | SEC |
| Friedman Paul A | 13D/A | 7.80%1.81M shares | – | Dec 12, 20251 filing | Dec 12, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 7.00%1.58M shares | −1.30 ppfrom 8.30% | Feb 14, 20255 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Madrigal Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 202610:34 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:34 PM ET | Janus Henderson Group PLC | 13G/A | 7.00%1.58M shares | −1.30 ppfrom 8.30% | Dec 31, 2025 | SEC |
| Dec 12, 20256:10 PM ET | Taub Rebecca | 13D/A | 7.80%1.81M shares | – | Dec 10, 2025 | SEC |
| Dec 12, 20256:10 PM ET | Friedman Paul A | 13D/A | 7.80%1.81M shares | – | Dec 10, 2025 | SEC |
| Nov 14, 202512:06 PM ET | Janus Henderson Group PLC | 13G/A | 8.30%1.84M shares | −1.60 ppfrom 9.90% | Sep 30, 2025 | SEC |
| Aug 14, 202511:24 AM ET | Janus Henderson Group PLC | 13G/A | 9.90%2.19M shares | −0.10 ppfrom 10.00% | Jun 30, 2025 | SEC |
| May 14, 202512:15 PM ET | Janus Henderson Group PLC | 13G/A | 10.00%2.21M shares | −0.10 ppfrom 10.10% | Mar 31, 2025 | SEC |
| Feb 14, 202512:10 PM ET | Janus Henderson Group PLC | 13G/A | 10.10%2.21M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Madrigal Pharmaceuticals, Inc. shares.
No Form 144 notices for Madrigal Pharmaceuticals, Inc. are on file.